1. Clinical Overview
A fixed-dose ophthalmic combination of Naphazoline, a sympathomimetic alpha-adrenergic agonist, and Chlorpheniramine Maleate, a first-generation alkylamine H1-antihistamine. It is primarily used for the symptomatic relief of allergic conjunctivitis. Naphazoline provides rapid vasoconstriction, reducing conjunctival redness and edema, while Chlorpheniramine competitively antagonizes histamine at H1 receptors, alleviating itching, tearing, and other allergic symptoms. This combination offers both immediate decongestant and sustained antihistaminic effects, making it a popular choice for acute allergic eye conditions in the Indian market.
| Onset | Duration | Bioavailability |
|---|---|---|
| Naphazoline: 2-5 minutes; Chlorpheniramine: 10-15 minutes. | Naphazoline: 2-6 hours; Chlorpheniramine: 4-6 hours. | Topical ophthalmic; systemic absorption is minimal (<5%). |
2. Mechanism of Action
The combination works via two distinct pathways. Naphazoline acts as a direct-acting sympathomimetic on alpha-1 adrenergic receptors on conjunctival vasculature, causing vasoconstriction. This reduces blood flow, capillary permeability, and edema, leading to decreased redness and swelling. Chlorpheniramine Maleate is a competitive reversible antagonist of histamine at H1 receptors. By blocking histamine binding, it inhibits the allergic response in conjunctival mast cells, preventing capillary dilation, permeability, and sensory nerve stimulation, thereby relieving itching, tearing, and redness.
3. Indications & Uses
- Allergic Conjunctivitis (Seasonal & Perennial)
- Acute Allergic Rhinoconjunctivitis
4. Dosage & Administration
Adult Dosage: One to two drops instilled into the affected eye(s). Usually used up to 3-4 times daily, or as directed by the physician. Do not exceed 4 instillations in 24 hours.
Administration: 1. Wash hands before use. 2. Tilt head back. 3. Gently pull lower eyelid down to form a pouch. 4. Instill the prescribed number of drops without touching the dropper tip to eye, eyelid, or any surface. 5. Close eyes gently and apply gentle pressure to the inner corner of the eye (nasolacrimal occlusion) for 1-2 minutes to minimize systemic absorption. 6. Wait at least 5 minutes before instilling any other eye medication.
5. Side Effects
Common side effects may include:
- Transient Stinging/Burning on instillation
- Mydriasis (pupil dilation)
- Blurred vision temporarily
- Headache
- Mild irritation
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Monoamine Oxidase Inhibitors (MAOIs) - e.g., Phenelzine, Tranylcypromine | Potentiation of pressor effects of Naphazoline, risk of hypertensive crisis. | Major |
| Tricyclic Antidepressants (TCAs) - e.g., Amitriptyline | Increased anticholinergic effects (dry eyes, urinary retention) and potentiation of pressor effects. | Moderate |
| Beta-blockers (Ophthalmic - e.g., Timolol) | Potential additive effect on intraocular pressure; may antagonize effects in glaucoma. | Moderate |
| Other CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Increased sedation and impaired alertness from Chlorpheniramine. | Moderate |
| Antihypertensives | Naphazoline may counteract hypotensive effect. | Moderate |
7. Patient Counselling
- DO wash hands before use.
- DO use exactly as prescribed; do not exceed dose/frequency.
- DO wait at least 5 minutes between different eye drops.
- DO practice nasolacrimal occlusion (pressing inner eye corner) for 1-2 minutes after instillation.
- DONT touch the dropper tip to any surface to avoid contamination.
- DONT wear contact lenses while using these drops or for at least 15 minutes after instillation.
- DONT use if the solution is discolored or contains particles.
- DONT use for more than 3-5 days continuously without consulting a doctor to avoid rebound redness.
8. Toxicology & Storage
Overdose: Topical: Severe rebound redness, corneal damage, severe mydriasis, increased IOP. Systemic (from ingestion or excessive topical use): CNS depression (drowsiness, sedation, coma) or paradoxical CNS stimulation (insomnia, hallucinations, convulsions - especially in children), cardiovascular effects (hypertension, bradycardia followed by tachycardia, arrhythmias, shock), anticholinergic crisis (hyperthermia, dry skin, flushed face, urinary retention).
Storage: Store at room temperature (15°C to 25°C). Protect from light. Do not freeze. Keep the bottle tightly closed when not in use. Keep out of reach and sight of children. Discard the bottle 28 days after first opening to prevent microbial contamination. Do not use after the expiry date printed on the label.